Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Ammonium Chloride | HCID 25517 | — |
| Reactant | HCID 68429289 | HCID 68429289 | — |
| Solvent | Ether tetrahydrofuran | HCID 21868444 | — |
| Product | HCID 68430452 | HCID 68430452 | 42% |
Reaction Steps
THF-diethyl ether solution (2.5 mL-2.5 mL) was added a solution of the compound obtained in step 1 (0.51 g) in THF-diethyl ether (2.5 mL-2.5 mL), and the resulting mixture was stirred at room temperature for 2 hr under a nitrogen atmosphere. 1N Aqueous sodium hydroxide solution (0.076 mL), saturated aqueous ammonium chloride (0.076 mL) and water (0.076 mL) were added, and the resulting mixture was stirred at room temperature for 3 hr. The precipitate was removed by filtration, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (solvent gradient; 0→40% ethyl acetate/hexane) to give 4-benzyl-8-(4-chlorophenoxy)-2,3,4,5-tetrahydropyrido[3,2-f][1,4]oxazepine (0.20 g, 42%) as a white powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08329687B2 |
|---|
| Source dataset | uspto-grants-2012_12 |
|---|
| ORD ID | ord-f8393af36e8844f6a3e9bedd1b1f01ef |
|---|
| Source note | uspto-grants-2012_12 |
|---|